Significantly improve the speed and quality of Radiology reporting by reducing unnecessary dictation, particularly for ultrasound and DEXA. Imorgon transfers modality measurements into Powerscribe/Fluency/RadAI merge fields/tokens, eliminating manual entry errors.
Imorgon's specialized services offer the following advantages:
- All measurements are always transferred (usually DICOM SR)
- Electronic worksheets capture findings and insert them into Powerscribe/Fluency/RadAI (rather than dictating from a worksheet)
- Worksheets with priors, calculators, and clinical decision support (TI-RADS, O-RADS, etc)
- Integrate into Epic or other EHRs
- Vendor neutral
- Support to ensure everything continues working
Significant improvement in the overhead of reporting with a quick ROI.
Learn more
QBench provides a comprehensive solution for monitoring all your samples and their positions within the workflow through a unified platform. By using QBench, you can forgo the traditional reliance on spreadsheets, shared network folders, and outdated paper tracking systems. The platform enables you to review numerous PDF reports and Certificates of Analysis (COAs) before finalizing or distributing them via email. You also have the option to create customizable barcodes and labels for your samples, ensuring compatibility with standard printers and scanners. Additionally, QBench features a billing module that streamlines the creation and dispatch of invoices directly from the system. Users can access data on counts and latencies for various data types within QBench, which encompasses metrics such as turnaround times, sample counts per test, delays, and more. This innovative tool simplifies the data collection process necessary for the assays conducted in your laboratory while enhancing overall efficiency. With QBench, managing your laboratory workflow has never been more straightforward and effective.
Learn more
NVIDIA Clara
Clara offers advanced tools and pre-trained AI models that are facilitating remarkable progress across a variety of industries, including healthcare technologies, medical imaging, pharmaceutical innovation, and genomic exploration. Explore the detailed workflow involved in the creation and application of medical devices through the Holoscan platform. Utilize the Holoscan SDK to design containerized AI applications in partnership with MONAI, thereby improving deployment capabilities in cutting-edge AI devices with the help of NVIDIA IGX developer kits. Additionally, the NVIDIA Holoscan SDK features acceleration libraries specifically designed for the healthcare sector, along with pre-trained AI models and sample applications that cater to computational medical devices. This strategic blend of tools not only promotes innovation and efficiency but also empowers developers to address intricate challenges within the medical landscape. As a result, the framework provided by Clara positions professionals at the forefront of technological advancements in healthcare.
Learn more
Genomenon
Pharmaceutical firms need a wealth of genomic information to successfully execute precision medicine strategies; however, they often utilize only a fraction—around 10%—of the total data at their disposal for decision-making. Genomenon offers an extensive database to counter this limitation. Their Prodigy™ Patient Landscapes deliver a cost-effective and efficient approach for conducting natural history research, which is crucial for developing treatments for rare conditions by expanding the understanding of both past and future health data. Employing a sophisticated AI-driven process, Genomenon meticulously analyzes each patient referenced in the medical literature much faster than traditional methods. It is essential to capture all pertinent insights by examining every genomic biomarker highlighted in scholarly articles. Each scientific assertion is backed by solid evidence sourced from medical literature, enabling researchers to identify all genetic factors and pinpoint variants classified as pathogenic according to ACMG clinical criteria, thus streamlining the creation of targeted therapies. By adopting this thorough strategy, pharmaceutical companies can significantly boost their research efficiency and, in turn, enhance patient outcomes. This innovative model not only fosters advancements in drug development but also contributes to a deeper understanding of genetic influences on health.
Learn more
